Back to Search Start Over

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2024.2.

Authors :
Bazhenova L
Ismaila N
Abu Rous F
Alluri K
Freeman-Daily J
Halmos B
Malhotra N
Marrone KA
Puri S
Qin A
Leighl NB
Source :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Dec 20; Vol. 42 (36), pp. e72-e86. Date of Electronic Publication: 2024 Nov 12.
Publication Year :
2024

Abstract

Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See the Appendix for disclaimers and other important information (Appendix 1 and Appendix 2 , online only). Updates are published regularly and can be found at https://ascopubs.org/nsclc-da-living-guideline .

Details

Language :
English
ISSN :
1527-7755
Volume :
42
Issue :
36
Database :
MEDLINE
Journal :
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
39531596
Full Text :
https://doi.org/10.1200/JCO-24-02133